Medical advances can be liberating
You can also reference this fact sheet from WADA for more information
In this 52-week, 1,098-patient randomized trial, both the 0.75- and 1.5-mg doses of once-weekly dulaglutide proved superior to oral sitagliptin (Januvia) at the standard dose of 100 mg/day in key efficacy endpoints
The specific deadline that applies to your case depends on when your injury occurred and when you discovered, or reasonably should have discovered, its connection to the medication
In a pure telogen effluvium it is therefore often not needed at all, because the hair comes back anyway
Wegovy and cardiovascular risk reduction In March 2024, the FDA approved Wegovy to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight